HRT Financial’s Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50 GROV.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-15,000
Closed 3618
2023
Q1
$0 Hold
15,000
﹤0.01% 3477
2022
Q4
$1K Hold
15,000
﹤0.01% 2394
2022
Q3
$3K Hold
15,000
﹤0.01% 2641
2022
Q2
$6K Buy
+15,000
New +$7.53K ﹤0.01% 2732

Other funds holding GROV.WS

HRT Financial's GROV.WS Position: Q2 2023 in Review

HRT Financial sold out of Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50 (GROV.WS) in Q2 2023, closing a stake of 15,000 shares.

HRT Financial first reported a position in GROV.WS in Q2 2022 and held it in 4 quarters. The position peaked at $6K in Q2 2022. 5 funds tracked by Wall St. Rank hold GROV.WS as of Q2 2023.

  • HRT Financial reported no remaining Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50 position as of Q2 2023 after selling out during the quarter.
  • HRT Financial sold 15,000 Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50 shares in Q2 2023.
  • HRT Financial first reported a position in Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50 in Q2 2022 and held it in 4 quarters.
  • HRT Financial's Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50 position peaked at $6K in Q2 2022.
  • 5 funds tracked by Wall St. Rank held Grove Collaborative Holdings, Inc. Each whole warrant is exercisable for one-fifth of a share of Class A Common Stock at an exercise price of $57.50 as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.